MUSC Health Florence Medical Center

As a component of the Medical University of South Carolina, MUSC Health Florence is a developing NCORP site, with an Oncology division led by a nationally-recognized, board-certified radiation oncologist. MUSC Health Florence will soon be active on the following clinical trials. Ask your health care provider for more information.

Genitourinary — Prostate

• GU010: Two Studies for Patients with Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients with a Low Gene Risk Score and Testing a More Intense Treatment for Patients with a Higher Gene Risk Score (PENDING)
  This trial uses the Decipher risk score to guide therapy selection. Decipher score is based on the activity of 22 genes in prostate tumors and may predict how likely it is for recurrent prostate cancer to spread (metastasize) to other parts of the body.